Latest Construction News

Sparc Technologies has progressed to Stage 2 of its Sparc Hydrogen joint venture with pilot plant commissioning slated for mid-2025, while also securing its first patent for photocatalytic water splitting technology in Morocco. Concurrently, its graphene-based additive ecosparc® demonstrates promising field trial results, underpinning commercial momentum.

Pointerra Limited’s Q3 FY25 results reveal delayed invoicing milestones pushed into Q4, yet strong progress across multiple sectors and promising product development underpin an optimistic cashflow outlook.

Adriatic Metals delivered a strong Q1 2025 with a 46% jump in silver equivalent production and a 26% rise in sales, setting the stage for commercial production in Q2. Key infrastructure milestones and debt repayments underpin confidence in the company’s growth trajectory.

Vanadium Resources Limited has extended its EPC and financing MOU with China Energy and raised A$783,000 via convertible notes, supporting ongoing development of its Steelpoortdrift Vanadium Project amid cost controls and regulatory progress.

Equatorial Resources has postponed its final arbitration hearing against the Republic of Congo to November 2025, while advancing exploration at its Nimba Alliance Iron Ore Project with promising high-grade results.

Xanadu Mines has transitioned operatorship of its flagship Kharmagtai project to Zijin Mining, delivered key feasibility milestones, and is now exploring strategic funding and corporate options amid a solid cash position.

Silver Mines Limited reports steady progress on its flagship Bowdens Silver Project and initiates diamond drilling at the Elsienora Gold Project, while navigating complex regulatory hurdles in New South Wales.

Jupiter Mines reported a robust Q3 FY2025 with higher manganese production and sales at Tshipi, driving a 65% jump in EBITDA amid improved prices and reduced costs.

Northern Minerals has made significant progress on its Browns Range Heavy Rare Earths Project, advancing its feasibility study and exploration while raising $41.5 million, positioning itself as a strategic alternative amid growing geopolitical supply risks.

Actinogen Medical advances its XanaMIA phase 2b/3 Alzheimer’s trial with faster patient enrolment and expands clinical sites, while achieving a pivotal FDA meeting outcome for its depression program. The company maintains a strong cash position, supporting ongoing development and commercialization efforts.

Galan Lithium has locked in a binding funding and offtake agreement with Authium Limited for its Hombre Muerto West project, significantly reducing capital and operating costs. The company raised approximately A$13 million via placement and plans further shareholder funding, aiming for lithium chloride production in H1 2026.

Red Sky Energy reports steady cash flow from its Innamincka Dome projects and advances development at Killanoola, while securing a significant 35% stake in offshore Angola’s Block 6/24 with promising oil resource estimates.